QNRX 8-K 2026-11-06

Quoin Pharmaceuticals Ltd. (QNRX) 8-K dated 2026-11-06 — accession 0001104659-26-123960.

Quoin Pharmaceuticals Ltd. (QNRX) is a biotechnology company listed on NASDAQ.

QNRX: and Reports Third Quarter 2026 Financial Results

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for QNRX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The QNRX SEC hub lists recent forms. The stock page is the research view.